I. Materials and methods:
A. Implantation of radiotelemeters, and electrocardiogram acquisition and analysis.
Radiotelemeters were implanted in all animals as previously described (Hazari et al. 2009 ); this methodology was used to track changes in cardiovascular function by monitoring ECG and HR.
Briefly, animals were weighed and anesthetized with ketamine hydrochloride/xylazine hydrochloride solution (1ml/kg, ip Sigma-Aldrich, St. Louis, MO). Using aseptic technique, each animal was implanted with a radiotelemetry transmitter (Model TA11CTA-F40, Data Sciences International, St. Paul, MN) in the abdominal cavity through a small incision. The electrode leads were guided through the abdominal musculature via separate stab wounds and tunneled subcutaneously across the lateral ventral thorax; the distal portions of the leads were secured in positions that approximated those of the lead II of a standard electrocardiogram (ECG). Body heat was maintained both during and immediately following the surgery. All animals were allowed 7-10 days to recover from the surgery and reestablish circadian rhythms. Using a remote receiver (DataART2.1: Data Sciences International, Inc., St. Paul, MN), ECG waveforms were continuously acquired and saved during the 5-min baseline period and aconitine challenge, which did not last longer than 40mins. HR was obtained from the ECG.
ECGAuto software (EMKA technologies USA, Falls Church, VA) was used to visualize individual ECG signals, analyze and quantify ECG segment durations and identify cardiac arrhythmias. Using ECGAuto, P wave, QRS complex, and T wave were identified for individual ECG waveforms and compiled into a library and used for analysis of all experimental ECG traces. The following parameters were determined for each ECG waveform: PR interval, QRS duration, QT corrected for HR (QTc) using Bazett's formula, and ST interval. The Lambeth conventions (Walker et al. 1988) were used as guidelines for the identification of cardiac arrhythmic events in rats. Arrhythmias were identified as occurring sequentially during aconitine challenge as ventricular premature beats (VPBs), ventricular tachycardia (VT) and ventricular fibrillation (VF).
Heart rate variability (HRV) was also calculated as the mean of the differences between sequential HRs for the complete set of ECG signals. For each 1-min stream of ECG waveforms, mean time between successive QRS complex peaks (RR interval), mean HR, and mean HRVanalysis-generated time-domain measures were acquired. The time-domain measures included standard deviation of the time between normal-to-normal beats (SDNN), and root mean squared successive differences (RMSSD). HRV analysis was also conducted in the frequency domain using a fast-Fourier transform. In this study, the spectrum was divided into low-frequency (LF) and high-frequency (HF) regions. The ratio of these two frequency domains (LF/HF) was calculated as an estimate of the relative balance between sympathetic (LF) and vagal (HF) activity.
B. Diesel exhaust generation and exposure. wDE for exposure experiments was generated using a 4.8 kW (6.4 hp) direct injection single-cylinder 0.320 L displacement Yanmar L70 V diesel generator operated at a constant 3600 rpm. Resistance heating elements provided a constant 3 kW load. Low sulfur diesel fuel (32 ppm), purchased from a local distributor was available from a large storage tank. Engine lubrication oil (Shell Rotella, 15W-40) was changed before each set of exposure tests. . Samples were extracted through fixed stainless steel probes in the exposure chambers. Gas samples were passed through a particulate filter prior to the individual gas analyzers. Dilution of air was adjusted periodically to maintain target PM concentrations as measured by the TEOM.
Particle size distributions were characterized during each exposure using an engine exhaust particle sizer (EEEPS, TSI Inc., model 3090, St. Paul, MN). Chamber temperatures, relative humidity, and noise were also monitored, and maintained within acceptable ranges.
II. Tables
A. Supplemental Material, Table 1 High wDE 248.1 ± 18.5 4.9 ± 0.5 5.8 ± 1.2 4.5 ± 2.0
High fDE 228.7 ± 9.1 4.9 ± 1.1 6.1 ± 1.4 13.1 ± 7.5* Low wDE 267.8 ± 10.3 8.0 ± 1.6 10.4 ± 2.1 5.4 ± 1.0
Low fDE 259.7 ± 10.6 15.3 ± 5.2* 23.8 ± 9.5* 3.3 ± 0.9 II. Low wDE + HC030031 285.5 ± 11.7 5.1 ± 0.4 6.8 ± 0.7 1.8 ± 0.8
Air + HC030031 272.1 ± 20.4 3.0 ± 0.9 3.7 ± 1.0 2.6 ± 1.9
Low wDE + RR 237.9 ± 24.6 3.4 ± 0.8 4.2 ± 1.4 0.7 ± 0.1 Air + RR 238.6 ± 12.8 3.8 ± 0.6 5.3 ± 1.3 1.7 ± 1.1
Low wDE + SB366791 227.4 ± 14.1 § 5.9 ± 1.5 5.5 ± 1. 2.6 ± 1.9 3.4 ± 2.7 11.8 ± 3.1
Low wDE + guanethidine 240.8 ± 13.6 3.9 ± 1.0 4.6 ± 1.1 1.1 ± 0.3
Air + guanethidine 293.6 ± 10.1 6.1 ± 1.2 7.6 ± 1.9 2.6 ± 1.2
Low wDE + atropine 190.3 ± 9.0 § 1.2 ± 0.4 1.1 ± 0.1 § 0.3 ± 0.1 Air + atropine 241.0 ± 22.6 6.7 ± 2.9 7.7 ± 3. 
